Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?

Giovanni AdamiElisabetta GerratanaFabiola AtzeniCamilla BeniniElisabetta VantaggiatoDenise RottaLuca IdolazziMaurizio RossiniDavide GattiAngelo Fassio

Published in: Therapeutic advances in musculoskeletal disease (2021)

CS is an important determinant of functional disability in patients with chronic inflammatory arthritides. PsA appeared to be more vulnerable to CS. In addition, in the presence of CS, DAPSA did not adequately capture the occurrence of functional disability. Therefore, special attention should be paid to PsA patients, in whom the concomitant diagnosis of CS should be routinely ruled out.

Keyphrases

prostate cancer
multiple sclerosis
end stage renal disease
oxidative stress
ejection fraction
newly diagnosed
risk assessment
chronic kidney disease
radical prostatectomy
prognostic factors
peritoneal dialysis